Advertisement
Canada markets open in 6 hours 6 minutes
  • S&P/TSX

    21,793.90
    +5.42 (+0.02%)
     
  • S&P 500

    5,477.90
    +8.60 (+0.16%)
     
  • DOW

    39,127.80
    +15.64 (+0.04%)
     
  • CAD/USD

    0.7306
    +0.0007 (+0.09%)
     
  • CRUDE OIL

    80.71
    -0.19 (-0.23%)
     
  • Bitcoin CAD

    83,093.75
    -1,406.91 (-1.66%)
     
  • CMC Crypto 200

    1,262.45
    -3.69 (-0.29%)
     
  • GOLD FUTURES

    2,311.40
    -1.80 (-0.08%)
     
  • RUSSELL 2000

    2,018.12
    -4.23 (-0.21%)
     
  • 10-Yr Bond

    4.3160
    +0.0780 (+1.84%)
     
  • NASDAQ futures

    19,959.50
    -53.00 (-0.26%)
     
  • VOLATILITY

    12.55
    0.00 (0.00%)
     
  • FTSE

    8,221.04
    -4.29 (-0.05%)
     
  • NIKKEI 225

    39,341.54
    -325.53 (-0.82%)
     
  • CAD/EUR

    0.6827
    -0.0004 (-0.06%)
     

Stocks in play: Eupraxia Pharmaceuticals Inc.

Announced that results from its Phase 2 study of EP-104IAR for the treatment of osteoarthritis of the knee will be presented at the upcoming European Alliance of Associations for Rheumatology European Congress of Rheumatology 2024 (the "Meeting"). The EULAR Meeting is being held in Vienna, Austria from June 12-15. Eupraxia Pharmaceuticals Inc. shares T.EPRX are trading up $0.01 at $3.70.

Read: